PeriFlow Therapeutics is a Boston-based biotech advancing a first-in-class treatment for capillary no-reflow after heart attack.

Case Studies

Showing 1 Success Stories about Software and Services used by PeriFlow Therapeutics

PeriFlow Therapeutics achieves a review-ready Phase 1 design in two weeks with AIRA Health

No matching case studies